This is taking place anywhere predictive analytics prevent adverse events, diagnostic algorithms flag abnormalities human eyes might miss, and automated systems extend specialist expertise to underserved populations. The analysis examines current deployment data, adoption patterns, and the challenges shaping the implementation of AI in healthcare and the future of telehealth. FDA authorization of AI-enabled medical devices has more than doubled since 2022, with projections estimating growth to over $500 billion by 2032.

—Please visit https://www.globalmed.com/resources/the-future-of-ai-in-healthcare-2026-analysis-2 to read more.